SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-016588
Filing Date
2018-11-21
Accepted
2018-11-21 06:15:30
Documents
4
Period of Report
2018-11-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 33765
2 ex99-1.htm EX-99.1 123094
3 ex99-1_01.jpg GRAPHIC 13357
4 ex99-1_02.jpg GRAPHIC 11616
  Complete submission text file 0001493152-18-016588.txt   192914
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 181196965
SIC: 2834 Pharmaceutical Preparations